360 High-Risk Vulnerability Immunization Tool V2.0 vs Faronics Anti-Executable: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Faronics Anti-Executable: Application whitelisting solution that blocks unauthorized executables. built by Faronics. Core capabilities include Application whitelisting to block unauthorized executables, Protection against zero-day attacks and mutating malware, Defense against advanced persistent threats..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Faronics Anti-Executable differentiates with Application whitelisting to block unauthorized executables, Protection against zero-day attacks and mutating malware, Defense against advanced persistent threats.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Faronics Anti-Executable is developed by Faronics. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Faronics Anti-Executable serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Zero Day, Windows Security. Review the feature comparison above to determine which fits your requirements.